Hom, Milton M., OD, FAAO Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2007
NCT00489398
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 4)

Conjunctivitis, Allergic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7